- Identification of the first small molecule positive allosteric modulator of the Gastric Inhibitory Polypeptide Receptor
M. Harris, T. Rahman, G. Ladds. Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom,
- Identification of the NMDA receptor subtype involved in the development of disease during EAE
E. Wheeler; C. Bolton; J. Mullins; C. Paul
- Identification of the novel P2Y14 receptor in porcine isolated pancreatic arteries
Alsaqati M, Latif ML, Chan SLF, Ralevic V
- Identification of the site of endothelin A receptor antagonist-induced fluid retention
Kohan D, Strait K, Stricklett P, Chapman M, Stuart D
- Identification of transcriptional regulatory regions controlling CLTR1 expression in airway smooth muscle/
N.P Duroudier; I. Sayers; C. Swan; S.A Richards & I.P Hall.
- Identification of transmembrane 4 as a key site for the secondary, low affinity, conformation of the human β1-adrenoceptor.
JG Baker, RGW Proudman, SJ Hill
- Identifying FDA-approved drugs that boost endogenous FGF-20 for targeted repurposing in Parkinson's disease
E. J. Fletcher, A. D. Jamieson, G. Williams, S. Duty. Wolfson CARD, King's College London, London, United Kingdom
- Identifying potential biomarkers for breast cancer proliferation and angiogenesis
V. Petroni Magri1, A. G. Fenech1, M. T. Camilleri Podesta2, G. Grech3. 1Clinical Pharmacology and Therapeutics, University of Malta, Msida, Malta, 2Anatomy, University of Malta, Msida, Malta, 3Pathology, University of Malta, Msida, Malta
- Identifying the active conformation of the mGlu4 receptor positive allosteric modulator VU0155041: Implications for drug discovery
Harrak Y, Rovira X, Gonzalez Bulnes P, Malhaire F, Goudet C, Pin JP, Giraldo J, Llebaria A
- Identifying the Molecular Targets of Therapeutic Drugs
I Sethw Hassan, S Alexander